In combination or as monotherapy in the treatment of different cancer types (metastatic melanoma, metastatic renal cell carcinoma), anti-PD-1/PDL-1 drugs lead to pericarditis with an incidence of less than 1% (30). The gene discussed is PDCD1; the disease is metastatic melanoma.